Objectives: We aimed to elucidate the role and molecular mechanisms of FOXM1 in regulating metastasis in oesophageal squamous cell carcinoma (ESCC) as well as its clinical implications.
| INTRODUC TI ON
The incidence of oesophageal cancer has rapidly increased in the United States and western countries over the past decades. 1, 2 In Asia, oesophageal cancer is also one of the most aggressive cancers, with a high prevalence. 3 As a major subtype of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC) accounts for approximately 90%
of oesophageal cancers and has been ranked as the fourth leading cause of cancer-related mortality in China. 4 Oesophageal cancer has a poor prognosis due to early metastasis and direct invasion, the 5-year overall survival rate of which is less than 20%. 5 The majorities of oesophageal cancer patients develop resistance to both chemo-and radiotherapy despite initial response. [6] [7] [8] [9] [10] Moreover, patients with resistance to these treatments are frequently diagnosed with metastasis. 11, 12 Therefore, elucidation of the mechanisms involved in oesophageal cancer metastasis is urgently needed.
FOXM1 is strongly overexpressed in almost all types of human cancers and is highly associated with cancer progression, including that of oesophageal cancer. 13 In general, there are four distinct isoforms of FOXM1: FOXM1a, FOXM1b, FOXM1c and FOXM1d, due to the alternative splicing of its exons Va and VIIa. 13, 14 FOXM1a, which retains both exons Va and VIIa, is predominantly located in the cytoplasm and is transcriptionally inactive, probably due to the disruption of its transactivation domain. 15 Both FOXM1b (without both Va and VIIa) and FOXM1c (with only exon Va), which are predominantly located in the nucleus, play similar but not identical biological roles
and have different binding affinities and partners. 13 We recently identified FOXM1d as a novel FOXM1 isoform that has exon VIIa but lacks exon Va and is predominantly located in the cytoplasm;
thus, it does not have direct transcription-regulating functions.
14 FOXM1 has widely been recognized as a proliferation-specific oncogenic transcription factor 13 that transcriptionally regulates a number of genes that are involved in the G2-M progression, such as Plk1, AuroraB, Cyclin B1, CDC25B, CENP-A and Survivin. 16, 17 In addition, FOXM1 plays an essential role in the regulation of a wide spectrum of biological processes, such as inflammation, metabolism, angiogenesis, apoptosis and metastasis. [18] [19] [20] [21] Overexpression of FOXM1 is highly associated with tumour cell survival, epithelial-to-mesenchymal transition (EMT), chemo-/radio-resistance and metastasis. 18, 19 Downregulation of FOXM1 inhibits matrix metalloproteinases (MMPs), including MMP2 and MMP9, and inhibits nasopharyngeal carcinoma metastasis. 22, 23 FOXM1 is associated with metastasis in colorectal cancer through induction of EMT. 24 In oesophageal can- and 5% penicillin-streptomycin antibiotics (Gibco, Thermo Fisher Scientific) and were maintained at 37°C in a humidified incubator with 5% CO 2 . Figure S1B ).
| Plasmids, siRNA and transfection

| Western blot
Cancer cells were harvested and lysed with cell lysis buffer (Sigma, St. 
| Immunohistochemistry (IHC) assay
Cancer tissues from 120 paraffin-embedded ESCC patients were obtained from the tissue bank at Fudan University Shanghai Cancer
Center, and utilization of samples was approved by the Ethics Committee at Fudan University Shanghai Cancer Center. The ESCC paraffin-embedded tissues were cut into 5-μm-thick slices. The in situ expression of FOXM1c and IRF1 was detected by IHC staining using an anti-Va antibody and anti-IRF1 (ET1602028; HuaAn Biotechnology) antibody. Briefly, slices were deparaffinized in xylol, heated for antigen retrieval using 10 mmol/L sodium citrate (pH 6.0), treated with 3% hydrogen peroxide to inhibit endogenous peroxidase activity and blocked using 1% BSA/PBS. Slices were put in a wet box and incubated with anti-Va and anti-IRF1 antibody at 4°C overnight. Reactions were developed using GTvision TM III (GK500710;
Gene Technology, Shanghai, China) and counterstained with 10%
haematoxylin. Finally, slices were dehydrated and mounted with resinene. The staining index (0-12) was defined as the staining intensity (negative (0); weak (1); moderate (2); strong (3)) multiplied by the proportion of positive staining (0%-25% (1); 25%-50% (2); 50%-75% (3); 75%-100% (4)). The staining results were scored by two experienced pathologists blinded to the clinical data.
| Construction of reporter plasmids
A 958 bp sequence from −820 to +138 bp of IRF1 (NM_002198.2) relative to the transcriptional start site was subcloned into the KpnI and XhoI sites of the pGL3-basic vector (Promega), using the following primers: forward-KpnI:
5'-CGGGTACCCGACCTTGAAAACTACTCAGC-3' and reverse-XhoI: 
| In vitro migration and invasion assay
| Dual luciferase assay
For analysis of the effect of FOXM1c on regulating IRF1 transcription, we employed dual luciferase reporter assays as described previously. 29 In brief, 293T cells were transiently transfected with the different pGL3-IRF1 plasmids together with FOXM1c-expressing or FOXM1c shRNA plasmid. The IRF1 promoter activity was normalized via co-transfection with a Renilla luciferase reporter gene. The luciferase activity was quantified using a dual luciferase assay kit (Promega) 48 hours after transfection.
| Chromatin immunoprecipitation (ChIP) assay
ChIP assays were used to identify the physical binding of 
| Statistical analysis
Statistical evaluation was conducted with SPSS 22.0 (SPSS Inc., Chicago, IL). The chi-square test was used to analyse the relationship between clinicopathological parameters and the expression of CD59.
The 5-year overall survival (OS) and disease-free survival (DFS) were calculated by the Kaplan-Meier method, and differences in variables were compared using log-rank tests. The significance of the in vitro and in vivo data was determined using Student's t test (two-tailed).
All data are shown as the mean ± SD Experiments were repeated at least three times. P values less than 0.05 were considered significant.
| RE SULTS
| FOXM1c was the predominant isoform in ESCC cells
Although isoform with specific primers. 14 We observed that the FOXM1c isoform was uniformly expressed at a much higher level than the other three isoforms in all four cell lines ( Figure 1B and Figure S1A ), indicating the potential importance of FOXM1c in oesophageal cancer progression. The mRNA level of another isoform, FOXM1b, followed that of FOXM1c but was at a much lower level, whereas the other two isoforms, FOXM1a and FOXM1d, were undetectable at the mRNA level ( Figure 1B ).
To further verify the expression of FOXM1c at the protein level,
we generated a mouse monoclonal antibody (McAb) directly against the exon Va (thus named Va), which is only contained in FOXM1a and FOXM1c. 32 Considering that FOXM1a was negligibly expressed in ESCC ( Figure 1B ) and in pancreatic and colorectal cancers as described previously, 14 found that the pattern of FOXM1c expression in four ESCC cells was consistent with FOXM1 expressed at similar levels ( Figure 1C ).
Therefore, we concluded that FOXM1c was the predominant isoform in ESCC cells.
| Genetic alteration of FOXM1c expression level affected ESCC cell metastasis
Given the evidence that FOXM1 coincides with metastasis of breast cancer, pancreatic cancer and prostate cancer, 
| IRF1 mediated FOXM1c-induced cell migration and invasion via MMP2/9
To identify the downstream targets that are potentially regulated by FOXM1c and simultaneously contribute to oesophageal cancer metastasis, we next tested 15 previously reported genes that are regulated by FOXM1 and highly associated with cancer metastasis ( Figure   S4 ). 23, [36] [37] [38] [39] [40] To identify which gene is responsible for FOXM1c regulation of ESCC cell metastasis, we assessed the alterations of mRNA In addition, based on the GEO public database analysis, we found that IRF1 expression in oesophageal cancer was significantly higher than that in paired normal tissues, indicating a positive correlation between IRF1 and oesophageal cancer progression (GSE23400) ( Figure 3E ).
Therefore, we chose IRF1 for further investigation.
Furthermore, we silenced IRF1 with shRNA to identify the subsequent alterations of MMP2/9 and the effects on cell migration
and invasion. The results demonstrated that both MMP2 and MMP9
were substantially downregulated in Eca109 and KYSE180 cells ( Figure 3F,G) . Accordingly, the cell migration and invasion capacities were strongly suppressed ( Figure 3H ,J, the quantitative results shown in Figure 3I ,K). Knockdown of IRF1 with specific siRNAs also impaired the wound healing abilities ( Figure S3C,D) . Therefore, these findings suggest that FOXM1c promoted oesophageal cancer metastasis, at least in part, by regulating the IRF1-MMP2/9 signalling axis.
| FOXM1c regulated IRF1 transcription
To further reveal the mechanism of IRF1 transcription regulated by Therefore, we concluded that FOXM1c effectively regulated IRF1
transcription by directly binding to the specific promoter region.
| IRF1 was highly associated with FOXM1c and both were correlated with oesophageal cancer progression
To investigate the relationship between the expression levels of and a high tumour stage (Table 1) . Together, these results indicate that both FOXM1c and IRF1 were independent prognostic indicators and might be potential drug targets for oesophageal cancer.
| D ISCUSS I ON
FOXM1 produces four isoforms due to alternative splicing. FOXM1a function has been poorly characterized due to its extremely low scription. [43] [44] [45] Here, we interestingly found that the transcription factor of IRF1 simultaneously regulated both MMP-2 and MMP-9
in oesophageal cancer cells, possibly at the transcriptional level that requires future investigation, thus affecting cancer metastasis.
As a transcription factor, FOXM1 regulates many genes that are involved in different stages of cancer, including initiation, progression and metastasis. 13, 21, 32 We screened a series of genes that are important for tumour metastasis and highly associated with FOXM1 expression. IRF1 was uniformly identified to be significantly downregulated by FOXM1c insufficiency in three oesophageal cancer cell lines. IRF1 is a transcription factor that regulates a number of IFN-inducible genes in response to viral infection or interferon stimulation. 46 The role of IRF1 in cancer progression is controversial depending on cancer types. 47, 48 Our current study demonstrated that IRF1 was transcriptionally regulated by FOXM1c
and was an important regulator for the oesophageal cancer cell invasion and migration via MMP2/9. We also found that there was a high correlation between FOXM1c and IRF1 in 120 oesophageal cancer specimens; more importantly, both FOXM1c and IRF1 were co-overexpressed in oesophageal cancer patients in the advanced stage and with poor prognosis. Therefore, FOXM1c and IRF1 may be potential independent biomarkers for prediction of oesophageal cancer prognosis.
In summary, we determined that FOXM1c was the predominant isoform among the four isoforms of FOXM1 in oesophageal cancer.
Moreover, we unveiled a novel mechanism of FOXM1c in regulating cancer invasion and migration, that is, 
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